Tocqueville Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.3M Sell
91,910
-3,198
-3% -$184K 0.07% 206
2026
Q1
$5.77M Buy
95,108
+5,661
+6% +$330K 0.09% 197
2025
Q4
$4.82M Sell
89,447
-23,114
-21% -$1.11M 0.07% 213
2025
Q3
$5.08M Sell
112,561
-1,202
-1% -$56.1K 0.07% 214
2025
Q2
$5.27M Buy
113,763
+20,181
+22% +$991K 0.08% 208
2025
Q1
$5.71M Sell
93,582
-1,073
-1% -$62.5K 0.09% 171
2024
Q4
$5.35M Sell
94,655
-584
-0.6% -$32.6K 0.08% 175
2024
Q3
$4.93M Sell
95,239
-25,223
-21% -$1.18M 0.08% 185
2024
Q2
$5M Sell
120,462
-904
-0.7% -$40.5K 0.08% 174
2024
Q1
$6.58M Sell
121,366
-275
-0.2% -$14K 0.11% 162
2023
Q4
$6.24M Sell
121,641
-272,000
-69% -$14.3M 0.11% 159
2023
Q3
$22.8M Sell
393,641
-1,588
-0.4% -$97.3K 0.43% 66
2023
Q2
$25.3M Sell
395,229
-2,244
-0.6% -$150K 0.45% 60
2023
Q1
$27.5M Buy
397,473
+14,940
+4% +$1.05M 0.52% 47
2022
Q4
$27.5M Buy
382,533
+832
+0.2% +$62.7K 0.52% 48
2022
Q3
$27.1M Sell
381,701
-799
-0.2% -$58K 0.55% 46
2022
Q2
$29.5M Buy
382,500
+20,146
+6% +$1.53M 0.54% 48
2022
Q1
$26.5M Sell
362,354
-5,711
-2% -$383K 0.4% 62
2021
Q4
$22.9M Sell
368,065
-889
-0.2% -$52.1K 0.32% 82
2021
Q3
$21.8M Sell
368,954
-642
-0.2% -$42.3K 0.32% 81
2021
Q2
$24.7M Sell
369,596
-22,234
-6% -$1.45M 0.36% 70
2021
Q1
$24.7M Sell
391,830
-4,958
-1% -$308K 0.38% 66
2020
Q4
$24.6M Buy
396,788
+728
+0.2% +$44.8K 0.41% 58
2020
Q3
$23.9M Sell
396,060
-21,864
-5% -$1.32M 0.46% 49
2020
Q2
$24.6M Sell
417,924
-17,043
-4% -$1.02M 0.51% 44
2020
Q1
$24.2M Sell
434,967
-13,753
-3% -$841K 0.6% 39
2019
Q4
$28.8M Buy
448,720
+29,738
+7% +$1.7M 0.42% 62
2019
Q3
$21.2M Sell
418,982
-6,700
-2% -$315K 0.29% 99
2019
Q2
$19.3M Buy
425,682
+247,675
+139% +$11.5M 0.25% 114
2019
Q1
$8.49M Buy
178,007
+6,090
+4% +$303K 0.11% 203
2018
Q4
$8.94M Sell
171,917
-385,821
-69% -$20.7M 0.13% 180
2018
Q3
$34.6M Sell
557,738
-91,668
-14% -$5.44M 0.44% 59
2018
Q2
$35.9M Sell
649,406
-3,080
-0.5% -$166K 0.46% 59
2018
Q1
$41.3M Sell
652,486
-9,481
-1% -$610K 0.53% 48
2017
Q4
$40.6M Sell
661,967
-855
-0.1% -$53.5K 0.46% 66
2017
Q3
$42.2M Sell
662,822
-10,692
-2% -$624K 0.49% 57
2017
Q2
$37.5M Sell
673,514
-9,325
-1% -$507K 0.45% 59
2017
Q1
$37.1M Buy
682,839
+22,141
+3% +$1.21M 0.45% 57
2016
Q4
$38.6M Sell
660,698
-81,911
-11% -$4.48M 0.49% 54
2016
Q3
$40M Sell
742,609
-4,969
-0.7% -$319K 0.48% 47
2016
Q2
$55M Buy
747,578
+16,069
+2% +$1.14M 0.66% 43
2016
Q1
$46.7M Buy
731,509
+91,168
+14% +$5.75M 0.62% 40
2015
Q4
$44M Sell
640,341
-5,155
-0.8% -$341K 0.6% 35
2015
Q3
$38.2M Sell
645,496
-15,929
-2% -$1.01M 0.51% 45
2015
Q2
$44M Sell
661,425
-1,625
-0.2% -$107K 0.52% 47
2015
Q1
$42.8M Sell
663,050
-11,310
-2% -$708K 0.5% 49
2014
Q4
$39.8M Buy
674,360
+85,967
+15% +$4.85M 0.43% 77
2014
Q3
$30.1M Sell
588,393
-778
-0.1% -$38.9K 0.33% 97
2014
Q2
$28.6M Buy
589,171
+222,824
+61% +$11M 0.28% 114
2014
Q1
$19M Sell
366,347
-16,663
-4% -$887K 0.25% 122
2013
Q4
$20.4M Buy
383,010
+44,215
+13% +$2.25M 0.27% 112
2013
Q3
$15.7M Buy
338,795
+44,861
+15% +$1.97M 0.2% 144
2013
Q2
$13.1M Buy
+293,934
New +$12.8M 0.18% 156

Other funds holding BMY

Tocqueville Asset Management's BMY Position: Q2 2026 in Review

Tocqueville Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 3.4% in Q2 2026, selling an estimated $184K and leaving 91,910 shares worth $5.3M. The position accounts for 0.07% of the portfolio, ranked #206.

Tocqueville Asset Management first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $55M in Q2 2016. 2,508 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Tocqueville Asset Management held 91,910 shares of Bristol-Myers Squibb worth $5.3M as of Q2 2026.
  • Tocqueville Asset Management sold 3,198 Bristol-Myers Squibb shares in Q2 2026, an estimated $184K.
  • Bristol-Myers Squibb made up 0.07% of Tocqueville Asset Management's portfolio in Q2 2026, its #206 holding.
  • Tocqueville Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
  • Tocqueville Asset Management's Bristol-Myers Squibb position peaked at $55M in Q2 2016.
  • 2,508 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Tocqueville Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.